Track the Unicycive Therapeutics, Inc. stock price and the full insider trade history of the company, a publicly traded company based in United States. Shares are listed on the US market, under the supervision of SEC (Form 4). Operating in the Health Care sector, Unicycive Therapeutics, Inc. has published 10 insider filings. Market capitalisation: €140.5m. The latest transaction was filed on 1 July 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: Aggarwal Gaurav. Every trade is free.
10
Insider Decl.
n/a
Thresholds
€11,855
1 ops.
Buy Volume
n/a
n/a
Sell Volume
40Σ signal
Buys €11,855n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.